» Articles » PMID: 37856527

Willingness to Use Long-acting Injectable PrEP Among HIV-negative/unknown Men Who Have Sex with Men in Mainland China: A Cross-sectional Online Survey

Overview
Journal PLoS One
Date 2023 Oct 19
PMID 37856527
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Men who have sex with men (MSM) are at high risk of HIV acquisition. Long-acting injectable-pre-exposure prophylaxis (LAI-PrEP), requiring less frequent dosing, is being studied as an alternative method to daily oral HIV PrEP. With the addition of this potential new prevention method, it expands the scope for a wider user choice and is expected to increase the acceptability and uptake of HIV prevention measures. The aim of our study was to explore the willingness to use LAI-PrEP and associated influential factors.

Methods: Participants were recruited from December 2020 to March 2021 through banner advertisements on web- and mobile app-based platforms on Blued, a large gay Chinese social media platform. MSM in our cross-sectional study was HIV-negative and currently lived in mainland China. Participants were asked about their willingness to use LAI-PrEP and reasons why they might be or not be willing to use LAI-PrEP. Multivariable logistic regression was used to analyze the factors associated with the willingness to use LAI-PrEP.

Results: In total, 969 participants met the inclusion criteria and finished the survey. Nearly twenty percent (19.5%) of participants had never tested for HIV; 66.8% of MSM had multiple male partners; and 51.6% of MSM engaged in condomless sex with their partner. About three-fifths (66.3%) of MSM were aware of PrEP, and only 3.9% of MSM had used PrEP before. The willingness to use LAI-PrEP among MSM was 74.0% (95% CI: 71.4%-76.6%). MSM with higher education levels were less likely to show a willingness to use LAI-PrEP (AOR = 0.56, 95%CI: 0.38-0.84). Participants who had a history of HIV test (AOR = 1.68, 95%CI: 1.11-2.55), were willing to use daily oral PrEP (AOR = 10.64, 95%CI:7.43-15.21), had multiple male sexual partners (AOR = 1.33, 95%CI:0.93-1.90), who used rush popper(AOR = 1.49, 95%CI:1.05-2.13), and who were aware of PEP (AOR = 1.66, 95%CI: 1.02-2.70) were more likely to show willingness to use LAI-PrEP.

Conclusions: In our study, MSM had quite high awareness but low uptake of PrEP. As LAI-PrEP is expected to be approved for use in China in the future, our study of MSM highlights the need for key population-focused education programs about PrEP and healthy sexual behavior. This study also provides some evidence for LAI-PrEP use among the Chinese MSM population in the future.

Citing Articles

Brief communication: attitudes and preferences of long-acting injectable HIV preexposure prophylaxis among Thai adolescents and young adults.

Wongsethanatada A, Songtaweesin W, Wongharn P, Moonwong J, Khamthi S, Pitikawinwong L AIDS Res Ther. 2025; 22(1):28.

PMID: 40025583 PMC: 11872299. DOI: 10.1186/s12981-025-00721-z.


Willingness to Use Long-Acting Injectable Pre-Exposure Prophylaxis among Adolescent Girls and Young Women in Kampala, Uganda.

Lunkuse J, Lwanga C, Wamono F, Muturi-Kioi V, Price M, Mayanja Y AIDS Behav. 2025; .

PMID: 39883369 DOI: 10.1007/s10461-025-04616-y.


Pre-exposure Prophylaxis (PrEP) Awareness and Engagement Among MSM at High Risk of HIV Infection in China: A Multi-City Cross-Sectional Survey.

Du J, Wang S, Zhang H, Liu T, Sun S, Yang C AIDS Behav. 2025; .

PMID: 39883368 DOI: 10.1007/s10461-025-04633-x.


Awareness, Intention to Use Pre-Exposure Prophylaxis, and Factors Associated with Awareness among Men Who Have Sex with Men in the Republic of Korea.

Jang S, Sohn A Trop Med Infect Dis. 2024; 9(8).

PMID: 39195608 PMC: 11359825. DOI: 10.3390/tropicalmed9080170.


Examining HIV Testing Coverage and Factors Influencing First-Time Testing Among Men Who Have Sex With Men in Zhejiang Province, China: Cross-Sectional Study Based on a Large Internet Survey.

He L, Jiang T, Chen W, Jiang S, Zheng J, Chen W JMIR Public Health Surveill. 2024; 10:e56906.

PMID: 38875001 PMC: 11214029. DOI: 10.2196/56906.

References
1.
Arifin B, Rokhman M, Zulkarnain Z, Perwitasari D, Manggau M, Rauf S . Adaptation and validation of the HIV Knowledge Questionnaire-18 for the general population of Indonesia. Health Qual Life Outcomes. 2022; 20(1):55. PMC: 8976362. DOI: 10.1186/s12955-022-01963-5. View

2.
Zhou F, Gao L, Li S, Li D, Zhang L, Fan W . Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS One. 2012; 7(3):e32329. PMC: 3316531. DOI: 10.1371/journal.pone.0032329. View

3.
Yigit M, Ozkaya-Parlakay A, Senel E . Evaluation of COVID-19 Vaccine Refusal in Parents. Pediatr Infect Dis J. 2021; 40(4):e134-e136. DOI: 10.1097/INF.0000000000003042. View

4.
Ding Y, Yan H, Ning Z, Cai X, Yang Y, Pan R . Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai, China. Biosci Trends. 2016; 10(2):113-9. DOI: 10.5582/bst.2016.01035. View

5.
Noble M, Jones A, Bowles K, DiNenno E, Tregear S . HIV Testing Among Internet-Using MSM in the United States: Systematic Review. AIDS Behav. 2016; 21(2):561-575. PMC: 5321102. DOI: 10.1007/s10461-016-1506-7. View